SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

GLAXOSMITHKLINE PHARMACEUTICAL

BSE: 500660 19 Aug 2025
Healthcare
₹ 2809.95
GlaxoSmithkline Pharmaceuticals Ltd. specializes in Pharmaceuticals within the Healthcare sector.

GLAXOSMITHKLINE PHARMACEUTICAL - Share Price & Details

Market Cap
₹46,621
High /Low
3,516 / 1,921
Stock P/E
49.2
Book Value
₹115.0
Dividend Yield
1.48
ROCE
63.2
ROE
₹46.9
Face Value
10.0
PEG Ratio
-2.51
EVEBITDA
₹33.4
Debt
9.95
CMP / FCF
60.9
Debt to equity
₹0.01
NP Ann
928
High price all time
3,516
Piotroski score
₹8.0
Graham Number
381.0
No. Eq. Shares
16.9
Net CF
₹475
Net profit
950
Price to book value
23.9
Interest Coverage
₹946.0
Low price all time
346.0
Industry PE
33.8
Reserves
₹1,782
Free Cash Flow
₹1,273

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
GLAXOSMITHKLINE PHARMACEUTICAL8485.92047.08048.312.0846,62149.2
Narayana Hrudayalaya Limited9595.77873.719431.414.33776347.8
Global Health Limited9052.951519.648821.565.653690664.7

Peer Comparison Chart


About GLAXOSMITHKLINE PHARMACEUTICAL

GlaxoSmithkline Pharmaceuticals Ltd., with Security Code 500660, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Glaxosmithkline Pharmaceuticals Outperforms Sector Amid Mixed Moving Average Trends

(14 Aug 2025)
Glaxosmithkline Pharmaceuticals experienced notable trading activity, outperforming its sector and reaching an intraday high.
Read more →

Glaxosmithkline Pharmaceuticals Adjusts Evaluation Amid Shifting Market Sentiment and Performance Metrics

(13 Aug 2025)
Glaxosmithkline Pharmaceuticals has recently adjusted its evaluation, indicating a shift in technical trends and market sentiment.
Read more →

Glaxosmithkline Pharmaceuticals Faces Continued Stock Decline Amid Broader Market Weakness

(07 Aug 2025)
Glaxosmithkline Pharmaceuticals has faced a significant decline, with its stock falling for five consecutive days and experiencing a total drop of 13.83%.
Read more →

GlaxoSmithKline Pharmaceuticals Limited Just Missed Revenue By 8.6%: Here's What Analysts Think Will Happen Next

(05 Aug 2025)
Shareholders might have noticed that GlaxoSmithKline Pharmaceuticals Limited ( NSE:GLAXO ) filed its first-quarter...
Read more →

GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) Q1 2026 Earnings Call Highlights: Strategic ... By GuruFocus

(04 Aug 2025)
GlaxoSmithKline Pharmaceuticals Ltd (BOM:500660) Q1 2026 Earnings Call Highlights: Strategic ...
Read more →

Glaxosmithkline Faces Significant Stock Decline Amid Broader Market Trends

(04 Aug 2025)
Glaxosmithkline Pharmaceuticals has faced a significant decline, with shares dropping 3.37% today and a total loss of 11.19% over the past...
Read more →

Company Updates